Reviews Write New Review
Report a problem with this profile
[email protected]
[email protected]
Janet Woodcock has held prominent positions within the Food and Drug Administration (FDA). As of my last update in January 2022, she was serving as the Acting Commissioner of the FDA until February 17, 2022. As Principal Deputy Commissioner, she works closely with the Commissioner to develop and implement key public health initiatives and oversees the agency's daily functions.
Woodcock's educational background includes a Bachelor of Science in chemistry from Bucknell University in Lewisburg, PA, and a Doctor of Medicine from the Feinberg School of Medicine at Northwestern University Medical School in Chicago. She is also board-certified in internal medicine.
Related Speakers View all
Dr. Joel Selanikio
Award-Winning Physician, Health & Technology Activis...
|
|
Toby Cosgrove
Executive Advisor & Former CEO & President at Clevel...
|
|
Charlotte Jones-Burton
Senior Vice President at Chinook Therapeutics
|
|
Georges C. Benjamin, MD
Executive Director, American Public Health Association
|
|
Giovanni Colella
Co-Founder & CEO at Castlight Health
|
|
Deepak Chopra
Co-Founder of The Chopra Center for Wellbeing
|
|
Jack Choi
CEO of Anatomage, a company specializing on 3D medic...
|
|
Margaret A. Hamburg
Foreign Secretary, National Academy of Medicine; For...
|
|
David Bloom
Professor of Economics & Demography at the Harvard S...
|
|
Christianna Gorin
Chief Growth & Strategy Officer at Ogilvy Health
|
|
Elizabeth Carpenter
VP of Policy & Research for the Pharmaceutical Resea...
|
|
Mandy Cohen
Director of the Center for Disease Control & Prevent...
|
|
Ashwin Vasan
Commissioner of the New York City Department of Heal...
|
|
Dr. John Boockvar
Vice Chair of the Department of Neurosurgery at Leno...
|
|
Ashish K. Jha, MD, MPH.
Dean of Brown University School of Public Health
|
|
Priti Krishtel
Co-Founder & Co-Executive Director of I-MAK; Health ...
|
|
Jeremy Knox
Policy and Advocacy Lead, Drug-Resistant Infections,...
|
|
Greg Friberg
Vice President, Global Development for Oncology, Amgen
|
|
Kelly Clark
Founder and President of Addiction Crisis Solutions
|
|
John LaMattina
Former President of R&D at Pfizer; Senior Partner at...
|